Furiex Pharmaceuticals, Inc.
DelistedCIK 1484478fmd_07E2KHYQ61C9EQZZ48WW4K5DJPManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Mar 31, 2014, 17 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 |
|---|---|---|---|---|---|
| Total revenues | 6 | 9 | 4 | 41 | 71 |
| Research and development | 12 | 50 | 44 | 70 | 83 |
| Selling, general and administrative | 3 | 8 | 9 | 11 | 13 |
| Total operating expenses | 15 | 59 | 53 | 81 | 95 |
| Operating income | (8) | (50) | (49) | (40) | (24) |
| Interest expense | – | – | 0 | 3 | 5 |
| Other non-operating income (expense) | 0 | 0 | 0 | 0 | 0 |
| Income before taxes | (8) | (50) | (49) | (43) | (29) |
| Income tax expense | – | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (8) | (50) | (49) | (43) | (30) |
| Net income | (9) | (55) | (49) | (43) | (30) |